2. Gene
  3. CALY - calcyon neuron specific vesicular protein Gene

CALY - calcyon neuron specific vesicular protein Gene

  • 基因
  • 蛋白
  • 疾病
  • 相关产品
  • 直系同源

中文名称：钙质细胞神经元特异性囊泡蛋白

种属: Homo sapiens

同用名: NSG3; DRD1IP

基因 ID: 50632 | 基因类型: protein coding

关于 CALY

Cytogenetic location: 10q26.3 Genomic coordinates (GRCh38): 10:133,324,072-133,336,896 (from NCBI)

This gene has 5 transcripts (splice variants), 169 orthologues and 2 paralogues. Biased expression in brain (RPKM 10.6), adrenal (RPKM 3.4) and 1 other tissue.

功能概要

该基因编码的蛋白质是 II 型单跨膜蛋白。在嘌呤能或毒蕈碱而非 β-肾上腺素能受体受到刺激后，它是最大刺激钙释放所必需的。编码的蛋白质与 D1 多巴胺受体相互作用，并可能与其他 DA 受体亚型和/或 GPCR 相互作用。[RefSeq 提供，2008 年 7 月]

The protein encoded by this gene is a type II single transmembrane protein. It is required for maximal stimulated calcium release after stimulation of purinergic or muscarinic but not beta-adrenergic receptors. The encoded protein interacts with D1 Dopamine Receptor and may interact with Other DA receptor subtypes and/or GPCRs. [provided by RefSeq, Jul 2008]

CALY 基因产物(2)

mRNA Protein Name
NM_001321617.2 NP_001308546.1 neuron-specific vesicular protein calcyon isoform 2
NM_015722.4 NP_056537.1 neuron-specific vesicular protein calcyon isoform 1
基因本体论
  • 分子功能
  • 生物过程
  • 细胞组分
分子功能 GO 注释 逻辑证据 参考文献 来源
enables clathrin light chain binding IDA
IDA: 通过直接分析推断
16595675 GOA
enables protein binding IPI
IPI: 通过物理相互作用推断
16595675 GOA
生物过程 GO 注释 逻辑证据 参考文献 来源
involved in clathrin coat assembly IDA
IDA: 通过直接分析推断
16595675 GOA
involved in positive regulation of endocytosis IMP
IMP: 通过突变表型推断
16595675 GOA
细胞组分 GO 注释 逻辑证据 参考文献 来源
located in cytoplasmic vesicle IDA
IDA: 通过直接分析推断
14534309 GOA
located in plasma membrane IDA
IDA: 通过直接分析推断
14534309 GOA
is active in postsynaptic endocytic zone IDA
IDA: 通过直接分析推断
16595675 GOA
is active in postsynaptic endocytic zone IMP
IMP: 通过突变表型推断
16595675 GOA
EXP：通过实验结果推断 IDA：通过直接分析推断 IPI：通过物理相互作用推断 IMP：通过突变表型推断 IGI：通过遗传相互作用推断 IEP：通过表达模式推断

CALY 蛋白结构

Calcyon

Calcyon: D1 dopamine receptor-interacting protein (calcyon) (1 - 197)

  • 0
  • 100
  • 200
  • 217 a.a.
蛋白主名 其他名称

neuron-specific vesicular protein calcyon

D1 dopamine receptor-interacting protein

CALY 蛋白互作信息

分类
蛋白名称 蛋白编号 互作蛋白 互作蛋白种属 互作蛋白编号 实验方法 参考文献
种属内
CALY Q9NYX4 CLTA Homo sapiens P09496
Anti Tag CoIP
16595675
种属间: 跨种属相互作用 种属内: 同种属相互作用

关联疾病

疾病名称 别名
Childhood Pilocytic Astrocytoma

Pediatric Pilocytic Astrocytoma
Glutaric Aciduria Iii

Glutaryl-Coa Oxidase Deficiency

Ga Iii

Glutaric Acidemia Type 3

GA3

Glutaric Aciduria Type 3

Glutaric Aciduria 3

Glutaric Acidemia Type Iii

Glutaric Aciduria Type Iii
Malignant Essential Hypertension

Accelerated Essential Hypertension
Schizophrenia

SCZD

Schizophrenia With Or Without An Affective Disorder

Schizophrenia 12

Schizophrenia, Susceptibility To

Schizophrenia-1

Dementia Praecox

Schizophrenia 1
疾病名称 别名
Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

相关产品

Approval
生物活性分子 (91)
目录号 产品名 作用方式
纯度 是否罕见病
HY-15244 Alpelisib Inhibitor 99.95% 是
HY-101562 Inavolisib 99.96% 否
HY-N0215 L-Phenylalanine Antagonist 99.98% 否
HY-10341 Fasudil Hydrochloride 99.97% 是
HY-B0246 Carbamazepine 99.95% 是
HY-A0057 Gabapentin Inhibitor 98.0% 是
HY-13764 Tetrandrine Inhibitor 99.90% 是
HY-B0782 Acetazolamide 99.71% 是
HY-B0561 Spironolactone 99.63% 是
HY-12542 Dantrolene Inhibitor 98.38% 是
HY-70037 Cinacalcet Agonist 99.93% 是
HY-B0193A Prazosin hydrochloride 99.51% 否
HY-75161 (-)-Menthol Activator 99.79% 否
HY-B1221 Flufenamic acid 99.93% 否
HY-B1193 Terfenadine 99.98% 否
HY-14656 Diltiazem hydrochloride Antagonist 99.47% 是
HY-B1077 Penfluridol 99.93% 否
HY-17404 Cilnidipine Inhibitor 99.89% 是
HY-70037A Cinacalcet hydrochloride Agonist 99.98% 是
HY-B0632 Diltiazem Inhibitor 99.70% 是
HY-N1370 Tanshinone IIA sulfonate sodium Inhibitor 99.77% 否
HY-15553A Mibefradil dihydrochloride Inhibitor 99.71% 是
HY-B1546A Benzamil hydrochloride Inhibitor 99.70% 否
HY-75839 Dronedarone Hydrochloride 99.99% 否
HY-A0057A Gabapentin hydrochloride Inhibitor 98.0% 是
HY-B0358A Flunarizine dihydrochloride 99.36% 是
HY-B0782A Acetazolamide sodium 99.54% 是
HY-B0588 Brinzolamide Inhibitor 99.91% 否
HY-12542A Dantrolene sodium hemiheptahydrate Inhibitor 99.79% 是
HY-B0596 Taltirelin 99.91% 否
HY-B0109A Dorzolamide hydrochloride Inhibitor 99.86% 是
HY-10932 Aniracetam Modulator 99.94% 否
HY-A0082 Diphenidol hydrochloride Antagonist 99.95% 否
HY-14657 Dantrolene sodium Inhibitor 99.79% 是
HY-B1693 Levomepromazine 99.98% 否
HY-B1424 Benzthiazide Inhibitor 99.70% 否
HY-B1671 (+)-Kavain 99.98% 否
HY-B0684 Iopamidol 99.81% 否
HY-B1154 Penbutolol sulfate Antagonist 98.72% 否
HY-16952A Bepridil hydrochloride hydrate Antagonist 99.86% 否
HY-17613 Evocalcet Activator 98.39% 否
HY-B0021 Doxifluridine Inhibitor 99.44% 否
HY-B0473 Tetracaine hydrochloride Inhibitor 99.91% 否
HY-Y0258A Benzocaine hydrochloride 99.83% 否
HY-103370 Talniflumate Inhibitor 99.67% 是
HY-B0380A Trimebutine maleate 99.91% 是
HY-10341A Fasudil 99.91% 是
HY-B0551A Doxapram hydrochloride hydrate Inhibitor 99.28% 否
HY-Z0478 (-)-Limonene Inhibitor 98.59% 否
HY-B0380 Trimebutine 99.42% 是
HY-121186 Bevantolol hydrochloride Antagonist 98.98% 是
HY-U00212 Aranidipine Antagonist 99.12% 否
HY-16216 Gabapentin enacarbil Inhibitor 95.0% 是
HY-B0246R Carbamazepine (Standard) 99.97% 否
HY-108974 Drotaverine hydrochloride 99.65% 否
HY-112961 Patiromer Inhibitor 95.0% 否
HY-B0551 Doxapram Inhibitor 99.70% 否
HY-107319 Almitrine mesylate Inhibitor 99.81% 否
HY-109545 Isopropyl unoprostone Activator 95.10% 否
HY-B1471 Fluorometholone acetate Inhibitor 98.54% 否
HY-A0236 Aprindine Inhibitor 98.43% 否
HY-B0562 Methyclothiazide 99.76% 否
HY-109106A Upacicalcet sodium Agonist 99.91% 否
HY-A0135 Enflurane Inhibitor 98.0% 否
HY-B1457 Ouabain / 否
HY-10341C Fasudil dihydrochloride 99.98% 是
HY-128370 Calcium trinatrium diethylenetriaminepentaacetic acid hydrate Inhibitor 98.0% 否
HY-B0596A Taltirelin acetate 99.38% 否
HY-P1769 Angiotensin II (5-8), human 99.68% 否
HY-15553 Mibefradil Inhibitor / 否
HY-B0109 Dorzolamide Inhibitor / 否
HY-109106 Upacicalcet Agonist / 否
HY-10341B Fasudil hydrochloride semihydrate / 否
HY-106916 Unoprostone Activator 99.0% 否
HY-116790 (-)-Penbutolol Antagonist / 否
HY-121166 Levobetaxolol Antagonist / 否
HY-14656R Diltiazem hydrochloride (Standard) Antagonist / 否
HY-75839R Dronedarone Hydrochloride (Standard) / 否
HY-A0270 Diphenidol Antagonist / 否
HY-B0021R Doxifluridine (Standard) Inhibitor / 否
HY-B0109AR Dorzolamide hydrochloride (Standard) Inhibitor / 否
HY-B0193AR Prazosin hydrochloride (Standard) / 否
HY-B0401A Tolbutamide sodium Inducer / 否
HY-B0588A Brinzolamide hydrochloride Inhibitor / 否
HY-B0588R Brinzolamide (Standard) Inhibitor / 否
HY-B0632A Diltiazem malate Inhibitor / 否
HY-B1546 Benzamil Inhibitor / 否
HY-B1558 Bifemelane / 否
HY-P1792 Angiotensin II (1-4), human Agonist / 否
HY-P1792A Angiotensin II (1-4), human TFA Agonist / 否
HY-B1693R Levomepromazine (Standard) / 否
Clinical Phase
生物活性分子 (66)
目录号 产品名 作用方式
纯度 Phase
HY-N6687 Calcimycin 99.12% Phase 4
HY-160187 AAA 98.40% Phase 4
HY-N6687A Calcimycin hemicalcium salt / Phase 4
HY-N6687B Calcimycin hemimagnesium / Phase 4
HY-13898 Taselisib Inhibitor 99.75% Phase 3
HY-50694 Senicapoc Inhibitor 99.91% Phase 3
HY-10805 Almorexant 99.96% Phase 3
HY-17449 Fosbretabulin disodium 99.91% Phase 3
HY-15724 Vercirnon Antagonist 98.01% Phase 3
HY-10805A Almorexant hydrochloride 99.98% Phase 3
HY-145567 Fasedienol 99.81% Phase 3
HY-18256 Ombrabulin hydrochloride Inhibitor 99.57% Phase 3
HY-106449 Recoflavone 98.0% Phase 3
HY-14797 Ombrabulin Inhibitor 98.53% Phase 3
HY-Z7721 (Rac)-Beraprost sodium Inhibitor 99.0% Phase 3
HY-15855 Fosbretabulin tromethamine Modulator / Phase 3
HY-10358 MK-2206 dihydrochloride 99.99% Phase 2
HY-N1584 Halofuginone 99.28% Phase 2
HY-13513 U-104 Inhibitor 99.95% Phase 2
HY-135317 Emavusertib 99.97% Phase 2
HY-10007 NPS-2143 Antagonist 99.94% Phase 2
HY-108232 MK-2206 99.72% Phase 2
HY-N1584A Halofuginone hydrobromide 99.99% Phase 2
HY-115864 Osavampator Activator 99.74% Phase 2
HY-10167A Tecalcet Hydrochloride Modulator 99.66% Phase 2
HY-15293B JTV-519 hemifumarate Inhibitor 99.74% Phase 2
HY-100414 Soraprazan Inhibitor 99.78% Phase 2
HY-118467 Benzolamide Inhibitor 99.07% Phase 2
HY-10066 Nelivaptan Antagonist 99.89% Phase 2
HY-147301 Resomelagon Agonist 98.79% Phase 2
HY-B0340 Nefiracetam Activator 99.91% Phase 2
HY-15724A Vercirnon sodium Antagonist 98.04% Phase 2
HY-N0842 Bevirimat Inhibitor 99.82% Phase 2
HY-19721 ABT-639 Inhibitor 99.32% Phase 2
HY-100779 Rimacalib Inhibitor 99.14% Phase 2
HY-100298 Caldaret Inhibitor 98.35% Phase 2
HY-137459 Vocacapsaicin Agonist / Phase 2
HY-137459A Vocacapsaicin hydrochloride Antagonist 95.66% Phase 2
HY-135317B Emavusertib hydrochloride / Phase 2
HY-10357 MK-2206 free base / Phase 2
HY-10049 CP 122721 Antagonist / Phase 2
HY-100934 SC-9 Activator / Phase 2
HY-106904 Nexopamil Antagonist / Phase 2
HY-110312 JTV-519 fumarate / Phase 2
HY-113037B Farnesyl pyrophosphate Agonist / Phase 2
HY-121535 Levosemotiadil Inhibitor / Phase 2
HY-169115 PD-0299685 / Phase 2
HY-106415 Terflavoxate Antagonist / Phase 2
HY-106927 Bay Y5959 Agonist / Phase 2
HY-114826S Prostaglandin E2-1-glyceryl ester-d5 Activator / Phase 2
HY-108496 Sphingosine-1-phosphate Agonist 99.54% Phase 1
HY-100973A Adenosine 5′-diphosphoribose sodium 99.47% Phase 1
HY-101093 CA-170 Inhibitor 99.39% Phase 1
HY-100886 BAY1082439 98.02% Phase 1
HY-129851 NTP42 Antagonist 98.58% Phase 1
HY-107111 GSK1034702 Agonist 98.78% Phase 1
HY-16935 Mavatrep Antagonist 99.67% Phase 1
HY-120588 BI 639667 Antagonist 99.47% Phase 1
HY-126077 MTI-31 Inhibitor 99.98% Phase 1
HY-137458 Vevorisertib Inhibitor 98.03% Phase 1
HY-115681 (2R/S)-6-PNG Inhibitor 99.88% Phase 1
HY-133011 nAChR agonist 1 Agonist 98.35% Phase 1
HY-107111A GSK1034702 hydrochloride Agonist / Phase 1
HY-114793 AL-12180 Agonist / Phase 1
HY-118148 UK-66914 Inhibitor / Phase 1
HY-121701 SR33805 analog Antagonist / Phase 1
抗体抑制剂 (1)
目录号 产品名 作用方式
纯度 Phase
HY-P99409 Oregovomab 99.66% Phase 3
Pre-clinical Phase
生物活性分子 (880)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-13433 Thapsigargin 99.95% 否
HY-13434 Ionomycin 99.27% 否
HY-18723 Yoda 1 99.97% 否
HY-100545 BAPTA-AM Inhibitor 99.68% 否
HY-W009724 2-Aminoethyl diphenylborinate 99.86% 否
HY-101896 Fluo-4 AM ≥99.0% 否
HY-D0989 Rhod-2 AM ≥97.0% 否
HY-D0861 EGTA 98.0% 否
HY-P2149 Concanavalin A Inducer 94% 否
HY-N0219 Bicuculline Antagonist 99.97% 否
HY-100202 TPEN 99.91% 否
HY-19608 GSK1016790A 99.93% 否
HY-100168 BAPTA Inhibitor 98.10% 否
HY-100350 CA-074 methyl ester Inhibitor 99.34% 否
HY-13434A Ionomycin calcium 98.02% 否
HY-10588 Bay K 8644 Agonist 99.96% 否
HY-126010 Dooku1 Antagonist 99.93% 否
HY-103350 CA-074 Inhibitor 99.94% 否
HY-100831 YM-58483 Inhibitor 99.38% 否
HY-12323 ISX-9 Activator 99.19% 否
HY-118630 Vacuolin-1 Inhibitor 98.54% 否
HY-101455 CDN1163 Activator 99.90% 否
HY-15084B Dizocilpine Antagonist 99.95% 否
HY-134923 CA77.1 Inducer 99.98% 否
HY-138620 MCU-i4 Inhibitor 99.87% 否
HY-19805 STO-609 Inhibitor 98.20% 否
HY-119287 TSQ 99.50% 否
HY-100912 W-7 hydrochloride 99.96% 否
HY-153306 Zovegalisib Inhibitor 99.20% 否
HY-101379A 8-Bromo-cGMP sodium Inhibitor 99.89% 否
HY-100001 SKF-96365 hydrochloride 99.71% 否
HY-15754 CGP37157 Inhibitor 99.87% 否
HY-100560 Abscisic acid Inhibitor 99.73% 否
HY-113308A Taurolithocholic acid sodium salt Agonist 99.81% 否
HY-D1024 Coelenterazine h 99.41% 否
HY-103312 Xestospongin C Inhibitor 99.0% 否
HY-N6732 K-252a Inhibitor 99.45% 否
HY-D0973 EGTA-AM 99.77% 否
HY-P0256 Apamin Inhibitor 99.96% 否
HY-P1410B D-GsMTx4 Inhibitor 99.59% 否
HY-120691A GSK205 Antagonist 99.47% 否
HY-D1498 Mag-Fluo-4 AM 96.0% 否
HY-101897 Fura-2 AM ≥99.0% 否
HY-131614 TPC2-A1-N Inhibitor 99.86% 否
HY-P1410C D-GsMTx4 TFA Inhibitor 99.89% 否
HY-103319 Calmidazolium chloride Antagonist 99.94% 否
HY-108599 DCP-LA 98.0% 否
HY-108465 Pyr3 Inhibitor 99.90% 否
HY-123071 Box5 Antagonist 99.24% 否
HY-N0215S12 L-Phenylalanine-d5 Antagonist 99.90% 否
HY-D0716 Fluo-3AM ≥99.0% 否
HY-123071A Box5 TFA Antagonist 99.24% 否
HY-101044 PPADS tetrasodium 95.0% 否
HY-N1502 Carboxyatractyloside tripotassium 99.97% 否
HY-15515 SEA0400 Inhibitor 99.95% 否
HY-116330A Hyperforin dicyclohexylammonium salt 99.48% 否
HY-P0033 Argireline Inhibitor 99.77% 否
HY-107543 8-pCPT-2′-O-Me-cAMP sodium Activator 99.81% 否
HY-15124 (S)-(-)-Bay-K-8644 Agonist 99.10% 否
HY-15415 KB-R7943 mesylate Inhibitor 99.16% 否
HY-116429 Maresin 1 Inhibitor 99.00% 否
HY-135897 Urolithin C ≥98.0% 否
HY-W127512 5β-Cholanic acid 99.87% 否
HY-116522 AR420626 98.29% 否
HY-113037C Farnesyl pyrophosphate ammonium Agonist 95.0% 否
HY-N6778 Paxilline Inhibitor 99.91% 否
HY-133168 Englerin A Activator 99.50% 否
HY-101017 Palmitoylcarnitine chloride 98.0% 否
HY-107411 Bromoenol lactone Inhibitor 99.59% 否
HY-113328 Aminoadipic acid 99.86% 否
HY-N6789 KT5720 Inhibitor ≥99.0% 否
HY-N0043 Ginsenoside Rd Inhibitor 99.88% 否
HY-101906 DC260126 99.74% 否
HY-110105 NS8593 hydrochloride Inhibitor 99.76% 否
HY-W019981B Magnesium chloride hexahydrate, for molecular biology Activator 99.40% 否
HY-100168B BAPTA tetrapotassium Inhibitor 99.45% 否
HY-103474 Bicuculline methiodide Inhibitor 99.93% 否
HY-15416 NS309 Activator 99.09% 否
HY-P5712 Gramicidin S Inhibitor 99.89% 否
HY-B2149 Quadrol Activator 99.88% 否
HY-12949 ML204 Inhibitor 98.45% 否
HY-103660 18:0 LYSO-PE 99.0% 否
HY-19408 Pyr10 Inhibitor 99.95% 否
HY-157131 TRPV2-selective blocker 1 Inhibitor 99.84% 否
HY-Y1667 2,6-Dibromophenol Inhibitor 99.76% 否
HY-111208 CCT129957 Inhibitor 99.71% 否
HY-119401 CAY10444 Antagonist 98.0% 否
HY-P0189A ω-Conotoxin GVIA TFA Inhibitor 99.20% 否
HY-16697 CID 16020046 Antagonist 99.81% 否
HY-121119 MRS 1523 99.97% 否
HY-14229 TGR5 Receptor Agonist Agonist 99.71% 否
HY-126750 GNF362 Inhibitor 99.86% 否
HY-107658 SN 6 Inhibitor 99.79% 否
HY-N2522 Carboxyatractyloside dipotassium 99.57% 否
HY-W019981C Magnesium chloride hexahydrate, for cell culture Activator / 否
HY-Y0413 Biacetyl monoxime Inhibitor 98.0% 否
HY-120261 GB-88 Inhibitor 98.66% 否
HY-13103 NS 11021 Activator 99.51% 否
HY-N0515 Ophiopogonin D 99.80% 否
HY-P3278A Caloxin 2A1 TFA Inhibitor 99.92% 否
HY-N0601 Ginsenoside Rf Inhibitor 99.48% 否
HY-P1080A ω-Agatoxin IVA TFA Inhibitor 99.10% 否
HY-P1345A TLQP-21 TFA Agonist 99.90% 否
HY-103309 ML218 Inhibitor 99.49% 否
HY-114252 Strophanthidin Inhibitor 98.53% 否
HY-149662 TMDJ-035 Inhibitor 99.92% 否
HY-162501 Yaddle1 Agonist 99.14% 否
HY-D1903 Fura Red AM 91.00% 否
HY-I0096 Indole-2-carboxylic acid 99.86% 否
HY-W194810 MCU-i11 98.42% 否
HY-B0358 Flunarizine 99.93% 是
HY-103307 FPL64176 Agonist 99.86% 否
HY-N0607 Ginsenoside Ro 99.81% 否
HY-16690 BTS Inhibitor 99.74% 否
HY-33299 Serpin B9-IN-1 97.0% 否
HY-120072 PF-3450074 Inhibitor 98.89% 否
HY-100168A BAPTA tetrasodium Inhibitor 99.70% 否
HY-162426 UNC-CA2-103 Inhibitor 99.26% 否
HY-W048457 Palladium hydroxide on activated carbon(20%)(wetted with ca. 55% Water) Control ≥97.0% 否
HY-B0006C (R)-Carvedilol Inhibitor 98.78% 否
HY-P6292A KS-133 TFA Antagonist 99.27% 否
HY-17442 Azathramycin Inhibitor 99.85% 否
HY-16689 VU 0240551 Inhibitor 99.70% 否
HY-N0215S8 L-Phenylalanine-13C6 Antagonist 99.8% 否
HY-124416 ML604086 Inhibitor 99.78% 否
HY-12496 NS-1619 98.06% 否
HY-136409 N-Decanoyl-L-homoserine lactone 98.40% 否
HY-18071 BI-9627 Inhibitor 99.71% 否
HY-10171 NPS-2143 hydrochloride Antagonist 99.98% 否
HY-101360 1-EBIO Agonist 99.96% 否
HY-101015A OBAA 99.31% 否
HY-110153 NS19504 Activator 99.93% 否
HY-118010A (+)-Norfenfluramine hydrochloride Agonist 99.77% 否
HY-15671 GKA50 Activator 99.84% 否
HY-N0252 Catharanthine Inhibitor 99.65% 否
HY-112698 CA-5f 99.14% 否
HY-120528A GB-110 hydrochloride Agonist 99.86% 否
HY-108593 BMS-191011 Activator 99.56% 否
HY-110243 CAIX Inhibitor S4 Inhibitor 99.04% 否
HY-15292 S107 Ligand 99.77% 否
HY-N2500 Deoxypodophyllotoxin 99.87% 否
HY-N4104 Agaric acid 99.45% 否
HY-P0190A Iberiotoxin TFA Inhibitor 99.05% 否
HY-P1845 PACAP-38 (31-38), human, mouse, rat Inducer 98.99% 否
HY-103320A Calhex 231 hydrochloride Inhibitor 99.81% 否
HY-N0215S1 L-Phenylalanine-d8 Antagonist 99.90% 否
HY-103306 Ryanodine Inhibitor 99.35% 否
HY-106844A (+)-EMD 57033 Agonist 99.72% 否
HY-N0126 Xanthone Inhibitor 99.97% 否
HY-N2344 Procyanidin A1 Inhibitor 99.19% 否
HY-P0190 Iberiotoxin Inhibitor 99.71% 否
HY-P3278 Caloxin 2A1 Inhibitor 99.86% 否
HY-W131725 (+)-Norfenfluramine Agonist 99.92% 否
HY-12759 CARM1-IN-1 Inhibitor 95.0% 否
HY-157562 DS68591889 99.18% 否
HY-130118 MRGPRX1 agonist 1 Agonist 99.95% 否
HY-16992A W-54011 99.57% 否
HY-N0910 Notoginsenoside Ft1 98.0% 否
HY-101366 A-61603 Agonist 99.0% 否
HY-103316A Ned 19 Inhibitor 99.92% 否
HY-137790 Bicuculline methochloride Antagonist 99.35% 否
HY-14350 AC-55541 Agonist 99.40% 否
HY-N0084 Betulinaldehyde Inhibitor 98.72% 否
HY-120026 KB130015 98.45% 否
HY-16639 ML314 Agonist 99.52% 否
HY-B0782R Acetazolamide (Standard) 99.69% 否
HY-P1366 des-​Gln14-​Ghrelin 99.66% 否
HY-114400 TRPV4 agonist-1 free base Agonist 99.69% 否
HY-100712 DPO-1 Inhibitor 98.39% 否
HY-124873 SERCA2a activator 1 Activator 99.71% 否
HY-160099 20-5,14-HEDE 98.34% 否
HY-W001538 S-Propargylcysteine ≥97.0% 否
HY-101329 Anthracene-9-carboxylic acid Inhibitor 99.09% 否
HY-108607 PACOCF3 Inhibitor 98.0% 否
HY-12927 SX-517 Antagonist 99.90% 否
HY-34740 Ethylmalonic acid Inhibitor 98.0% 否
HY-D1024A Coelenterazine h hydrochloride 98.80% 否
HY-W110910 Eriochrome black T, Indicator / 否
HY-129440 N-(p-Coumaroyl) Serotonin Inhibitor 99.03% 否
HY-136460 Calcium ionophore I 99.6% 否
HY-145542 Isovalerylcarnitine chloride Activator 99.48% 否
HY-N6701 Dihydrocytochalasin B 99.0% 否
HY-N0215S10 L-Phenylalanine-13C9 Antagonist 98.09% 否
HY-101396 ICA-069673 Activator 99.20% 否
HY-135891 AZD2423 Antagonist 99.91% 否
HY-N0215S3 L-Phenylalanine-d2 Antagonist 99.00% 否
HY-N2081 Skimmianine Inhibitor 99.90% 否
HY-P10655 Caloxin 1C2 Inhibitor 98.86% 否
HY-P1821A Myelin Basic Protein TFA 99.73% 否
HY-P2847 Urocortin II, mouse Agonist 98.63% 否
HY-P3965 16-38-Thymosin β4 (cattle) Activator 98.05% 否
HY-N7848 Linoleamide Inhibitor 99.4% 否
HY-104058 Oregon-BAPTA Green 1AM 92.0% 否
HY-120597 SAK3 Activator 99.80% 否
HY-D1422 ER Thermo Yellow 96.91% 否
HY-N0215S5 L-Phenylalanine-15N Antagonist 98.10% 否
HY-N7690 3,5,7,3′,4′-Pentamethoxyflavone Inhibitor 99.69% 否
HY-P1075 CALP3 Inhibitor 98.57% 否
HY-P1845A PACAP-38 (31-38), human, mouse, rat TFA Inducer 98.33% 否
HY-P3089A Dendrotoxin K TFA Inhibitor 99.54% 否
HY-157453 CCR4 antagonist 4 Antagonist 99.72% 否
HY-12949A ML204 hydrochloride Inhibitor 99.74% 否
HY-12498 GV-58 Agonist 99.22% 否
HY-103442 CGP52411 Inhibitor 99.82% 否
HY-108464A Phenamil methanesulfonate Inhibitor 98.1% 否
HY-116291 4α-Phorbol 12,13-didecanoate 99.30% 否
HY-136909 SR33805 Antagonist 99.78% 否
HY-34740S Ethylmalonic acid-d3 Inhibitor 98.0% 否
HY-N15721 Tryptophan-cholic acid Agonist 98.68% 否
HY-N2060 Evocarpine 99.88% 否
HY-N7063 Nerol 98.97% 否
HY-P0188A ω-Conotoxin MVIIC TFA Inhibitor 99.95% 否
HY-P1077A CALP1 TFA 99.86% 否
HY-W181102 NFAT Inhibitor-2 Inhibitor 98.42% 否
HY-103277A BIM 23042 TFA Antagonist 96.20% 否
HY-117073 ITH12575 Inhibitor 99.14% 否
HY-136190 TRPC6-PAM-C20 Agonist 99.78% 否
HY-158779 Sulfane sulfur probe 4 97.3% 否
HY-D0202 Arsenazo III 95.0% 否
HY-E70200 Recombinant Kex2 protease / 否
HY-N8307 Syringaresinol 99.15% 否
HY-P1076A CALP2 TFA Antagonist 99.79% 否
HY-P4160 PDC31 Inhibitor 99.92% 否
HY-W041308 DCOIT Agonist 99.87% 否
HY-W749867 Ca(II)-EDTA disodium dihydrate 98.0% 否
HY-32933 4-Acetylphenylboronic acid Inhibitor 99.96% 否
HY-137175 TMBIM6 antagonist-1 Antagonist 98.92% 否
HY-160023 Elisrasib Inhibitor 98.50% 否
HY-100783 (-)-Bicuculline methobromide Antagonist 99.94% 否
HY-101087 Benzenesulphonamide Inhibitor 99.51% 否
HY-124594 CA inhibitor 1 Inhibitor 99.77% 否
HY-135746 OR-1896 99.04% 否
HY-136182A YM-244769 Inhibitor 99.22% 否
HY-136661 (-)-N6-Phenylisopropyl adenosine Agonist 99.45% 否
HY-162774A GRP75-IN-1 dihydrochloride Inducer 99.75% 否
HY-NP009 α-Lactalbumin 99% 否
HY-NP164 Concanavalin A-HRP / 否
HY-P1821 Myelin Basic Protein 98.98% 否
HY-P1831 Proadrenomedullin (1-20), human 99.71% 否
HY-P3187 exo-β-1,4-Xylosidase, Cellulosimicrobium cellulans sp. 21 / 否
HY-41076 Ca2+ channel agonist 1 99.71% 否
HY-100928 YS 035 hydrochloride Antagonist 99.15% 否
HY-108592 UCL 2077 Inhibitor 98.91% 否
HY-108608 o-3M3FBS 99.88% 否
HY-128678 ORM-10103 Inhibitor 99.43% 否
HY-136182 YM-244769 dihydrochloride Inhibitor 98.57% 否
HY-136980 Aspartylglutamate 99.79% 否
HY-145127 ETZ 99.84% 否
HY-N0215S11 L-Phenylalanine-13C9,15N Antagonist 99.52% 否
HY-N0215S7 L-Phenylalanine-3-13C Antagonist 99.56% 否
HY-N1940 β-Anhydroicaritin Inhibitor 99.69% 否
HY-N7575 Lacto-N-fucopentaose II 98.0% 否
HY-P0271A Syntide 2 TFA 99.22% 否
HY-P1247 Calcineurin autoinhibitory peptide Inhibitor 99.99% 否
HY-P2757 Phosphorylase kinase / 否
HY-W111226 Fmoc-His(3-Me)-OH Inhibitor ≥98.0% 否
HY-N7491A Ent-(+)-Verticilide Inhibitor 99.91% 否
HY-12759A CARM1-IN-1 hydrochloride Inhibitor 95.13% 否
HY-103308 TRAM-39 Inhibitor 99.66% 否
HY-103317 NAADP 95.8% 否
HY-129126 NC9 Inhibitor 99.98% 否
HY-146268 CaMKIIα-IN-1 Inhibitor 98.41% 否
HY-A0236A Aprindine hydrochloride Inhibitor 98.96% 否
HY-D0110A Fura-2 pentapotassium 97.0% 否
HY-P0256A Apamin TFA Inhibitor 98.35% 否
HY-P5189A His-D-beta-Nal-Ala-Trp-D-Phe-Lys-NH2 TFA 99.56% 否
HY-W010710 IPrAuCl Inhibitor 98.0% 否
HY-W012399 2,5-Di-tert-butylhydroquinone 99.90% 否
HY-N0215S2 L-Phenylalanine-13C Antagonist 99.66% 否
HY-111207 CA224 99.94% 否
HY-105118A Zaldaride maleate Antagonist 99.7% 否
HY-103320B (1R,2R)-Calhex 231 hydrochloride Control 99.07% 否
HY-107855S DL-Mevalonolactone-d7 99.27% 否
HY-108496S Sphingosine-1-phosphate-d7 Agonist 99.00% 否
HY-11000A CaMKP inhibitor sodium Inhibitor 98.06% 否
HY-121584 Lycoperodine-1 Agonist 99.82% 否
HY-125703 Ferutinin 99.23% 否
HY-13338 Mabuterol Agonist 99.96% 否
HY-147301A Resomelagon acetate Agonist 99.75% 否
HY-151917 Enpp/Carbonic anhydrase-IN-2 Inhibitor 99.76% 否
HY-161104 Kv2.1-IN-1 Inhibitor 98.64% 否
HY-18071A BI-9627 hydrochloride Inhibitor 98.01% 否
HY-B0493S1 Niflumic acid-13C6 Inhibitor 99.8% 否
HY-N1584C Halofuginone lactate 98.32% 是
HY-N2157 Pteryxin Inhibitor 99.96% 否
HY-N7117 1,4-Cineole Activator 95.0% 否
HY-P1250 RFRP-3(human) Agonist 99.43% 否
HY-P1479A Calmodulin-Dependent Protein Kinase II(290-309) acetate 98.45% 否
HY-P5914A Wasabi Receptor Toxin TFA Activator 99.49% 否
HY-W013857 Lavendustin C Inhibitor 98.32% 否
HY-N0742 Absinthin Agonist 98.0% 否
HY-14656S Diltiazem-d3 hydrochloride Antagonist 98.70% 否
HY-100402 CFMTI Antagonist 98.0% 否
HY-101428 NS-638 Inhibitor 99.84% 否
HY-103078 I-XW-053 Inhibitor 99.71% 否
HY-103317A NAADP tetrasodium 95.8% 否
HY-103472 FPR-A14 Agonist 98.58% 否
HY-103544 [D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P 98.48% 否
HY-10388 TTA-Q6 Antagonist 99.97% 否
HY-10388A TTA-Q6(isomer) 99.91% 否
HY-111527 PPZ2 99.92% 否
HY-119282 AZD6538 Inhibitor / 否
HY-121604 (Rac)-MEM 1003 Inhibitor 99.64% 否
HY-129496 NP-313 Inhibitor 99.58% 否
HY-131012 GoSlo-SR-5-69 Activator 99.26% 否
HY-131948 3-Chlorodiphenylamine Activator 98.74% 否
HY-13699 NBI-42902 98.65% 否
HY-155480 PSB-22034 Agonist / 否
HY-155516 KV1.3-IN-1 Inhibitor 98.34% 否
HY-15705 GPR35 agonist 2 98.84% 否
HY-163796 GPR183-IN-2 Inhibitor 99.90% 否
HY-165473 Hexadecylphosphoserine Activator / 否
HY-165473A Hexadecylphosphoserine TFA Activator 98.0% 否
HY-176550 ASIC1a antagonist-1 Antagonist / 否
HY-76779 4-(Chloromethyl)-7-hydroxycoumarin 98.01% 否
HY-B0782S Acetazolamide-d3 Inhibitor 99.95% 否
HY-B1221S1 Flufenamic acid-13C6 99.5% 否
HY-D0121A INDO 1 pentapotassium 96.43% 否
HY-D1631 Calcium Green-5N AM / 否
HY-N10772 Albanin A Inhibitor 97.67% 否
HY-N5130 Effusol Inhibitor 99.83% 否
HY-N6688 Verruculogen Inhibitor 98.08% 否
HY-N9404 6-Benzoylheteratisine Inhibitor 98.17% 否
HY-NP164B Concanavalin A-AF488 / 否
HY-P1387 β-Amyloid (1-40) (rat) Inducer 99.58% 否
HY-P1397A RVD-Hpα TFA Agonist 99.32% 否
HY-P3037A Imperatoxin A TFA Activator 98.65% 否
HY-P3617 Glucagon (22-29) Agonist 99.69% 否
HY-P3811A Autocamtide-3 acetate 99.62% 否
HY-W074975 CL 5343 Inhibitor 98.0% 否
HY-126789A DM-Nitrophen tertasodium 90.0% 否
HY-150135B D-myo-Inositol 1,4,5-trisphosphate tripotassium Activator 98.00% 否
HY-B0124S Zonisamide-d4 Inhibitor 99.38% 否
HY-145456 Gallium 8-Hydroxyquinolinate Inducer / 否
HY-101902 Quin-2AM / 否
HY-100718 SCH00013 Activator / 否
HY-101015 (2E)-OBAA / 否
HY-101693A Senazodan hydrochloride Inhibitor 99.84% 否
HY-104056 Fura Red / 否
HY-106784A (E)-Ajoene / 否
HY-107659 YM-244769 hydrochloride Inhibitor 99.02% 否
HY-107678 SEN12333 Agonist 98.45% 否
HY-110292 A-425619 99.96% 否
HY-111014 VK-II-36 Activator 99.63% 否
HY-112741 SB-209247 Antagonist 99.33% 否
HY-113037CS Farnesyl pyrophosphate-d2 triammonium Agonist 95.78% 否
HY-113970A Nebracetam hydrochloride Agonist 99.0% 否
HY-115745 Calmodulin antagonist-1 Antagonist 98.0% 否
HY-120514 JNc-440 98.04% 否
HY-120528 GB-110 Agonist / 否
HY-121825 U-44069 Control 98.0% 否
HY-12550 GW542573X Activator 98.79% 否
HY-126583 Nemadipine-A Inhibitor 98.0% 否
HY-129146S Doxapram-d5 hydrochloride Inhibitor 99.0% 否
HY-131040 NLRP3-IN-NBC6 Inhibitor 99.40% 否
HY-13617 Edatrexate / 否
HY-136395 Cartap Inducer / 否
HY-145384 ROC-0929 Inhibitor 99.62% 否
HY-147005 piCRAC-1 Inhibitor 98.24% 否
HY-147384 CXL-1020 ≥99.0% 否
HY-148135 hCAI/II-IN-6 Inhibitor 98.0% 否
HY-149301 hCAIX-IN-18 Inhibitor 98.52% 否
HY-15015 OT-R antagonist 1 Antagonist ≥98.0% 否
HY-151916 Enpp/Carbonic anhydrase-IN-1 99.57% 否
HY-15293A JTV-519 free base Inhibitor / 否
HY-15671A GKA50 quarterhydrate Activator ≥98.0% 否
HY-15809 (Rac)-Ibrutinib alkyne Inhibitor / 否
HY-16147 Combretastatin A1 phosphate 98.00% 否
HY-16489A Terodiline hydrochloride Antagonist 99.78% 否
HY-165607S MCB-22-174 99.78% 否
HY-169332 Piezo1 agonist 1-d2 / 否
HY-170360 UCB9386 Inhibitor 99.89% 否
HY-175416 Yoda2 / 否
HY-B1873 Methoxychlor Inducer 99.41% 否
HY-E70197A Calpain-1, Human Erythrocyte Modulator / 否
HY-N0126R Xanthone (Standard) Inhibitor 99.99% 否
HY-N0215S14 L-Phenylalanine-15N,d8 Antagonist 99.90% 否
HY-N0252A Catharanthine Tartrate Inhibitor 98.88% 否
HY-N2005 Cycleanine 99.80% 否
HY-N2359 Chelerythrine / 否
HY-N4267 Yangambin Inhibitor 98.27% 否
HY-P0271 Syntide 2 / 否
HY-P1077 CALP1 98.44% 否
HY-P1079 ω-Agatoxin TK Inhibitor ≥99.0% 否
HY-P11205A Cys-PKHB1 TFA Activator 99.43% 否
HY-P1424A Lei-Dab7 TFA Inhibitor 99.75% 否
HY-P1640 (Trp63,Trp64)​-​C3a(63-77) Agonist / 否
HY-P1805 Calmodulin Binding Peptide 1 Inhibitor 98.68% 否
HY-P3037 Imperatoxin A Activator / 否
HY-P3965A 16-38-Thymosin β4 (cattle) (TFA) Activator 98.14% 否
HY-P5154A Tamapin TFA Antagonist 98.79% 否
HY-P5914 Wasabi Receptor Toxin Activator / 否
HY-P5988 N-myristoyl-RKRTLRRL Inhibitor 99.37% 否
HY-P6013A wt hMLN TFA Inhibitor 95.0% 否
HY-Q40876 BBT Modulator 99.71% 否
HY-RS01776 CA9 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS11007 PPP2CA Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-101329S Anthracene-9-carboxylic acid-d9 98.94% 否
HY-101693 Senazodan Inhibitor / 否
HY-113040A (17R,18S)-Epoxyeicosatetraenoic acid Inhibitor 93.0% 否
HY-126789 DM-Nitrophen 98.40% 否
HY-12962 NMDA-IN-1 Antagonist 98.98% 否
HY-156663 Calcium Channel antagonist 2 Antagonist 98.0% 否
HY-70037AS Cinacalcet-d3 hydrochloride Agonist 97.63% 否
HY-B2217D Calcium hydroxide, ACS, 95% Inhibitor / 否
HY-I0096R Indole-2-carboxylic acid (Standard) Inhibitor 99.78% 否
HY-N0215S L-Phenylalanine-d7 Antagonist 99.90% 否
HY-RS10523 PIK3CA Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS21174 Ppp2ca Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-W587805 Perfluorohexane sulfonamide Inhibitor 81.50% 否
HY-113037S1 Farnesyl pyrophosphate-d3 Agonist / 否
HY-113308AS Taurolithocholic acid-d4 sodium Agonist 99.4% 否
HY-114400A TRPV4 agonist-1 Agonist / 否
HY-169964 TSPO/Carbonic Anhydrase Modulator 1 Modulator / 否
HY-B0551S Doxapram-d8 Inhibitor / 否
HY-B0782S1 Acetazolamide-13C2,d3 / 否
HY-102085 11-Deoxyglycyrrhetinic acid sodium Activator / 否
HY-103309A ML218 hydrochloride Inhibitor / 否
HY-125836 CCR4 antagonist 2 Antagonist / 否
HY-19805A STO-609 acetate Inhibitor / 否
HY-N1584B Halofuginone hydrochloride / 否
HY-B0632S Diltiazem-d6 Antagonist / 否
HY-N1369S Menthol-d4 / 否
HY-P2471 Neurogranin (48-76), mouse Inhibitor / 否
HY-100781 D-AP4 Antagonist / 否
HY-100783A (+)-Bicuculline methochloride Antagonist / 否
HY-100783B Bicuculline methobromide Antagonist / 否
HY-100843 L-AP6 / 否
HY-100981 MR-16728 hydrochloride / 否
HY-10167 Tecalcet Modulator / 否
HY-101685A Iganidipine di(hydrochloride) Antagonist / 否
HY-103078A I-XW-053 sodium Inhibitor / 否
HY-103277 BIM 23042 Antagonist / 否
HY-103309S ML218-d9 Inhibitor / 否
HY-103313 SR33805 oxalate Antagonist / 否
HY-103320 Calhex 231 Antagonist / 否
HY-103545 GIP (1-39) Agonist / 否
HY-105118 Zaldaride Inhibitor / 否
HY-106428 Icrocaptide Inhibitor / 否
HY-106761 Oxodipine Antagonist / 否
HY-106818A Monatepil maleate / 否
HY-106837 Israpafant Antagonist / 否
HY-107855S1 DL-Mevalonolactone-d3 / 否
HY-108163A SB-237376 / 否
HY-109106B (Rac)-Upacicalcet 95.0% 否
HY-110140 (E)-KN-93 phosphate Inhibitor 99.85% 否
HY-111198 YM-355179 fumarate / 否
HY-111214 K-14585 / 否
HY-112393 TX-1918 Inhibitor / 否
HY-112794 Topanol CA 98.11% 否
HY-113308AS2 Taurolithocholic acid-d4-1 sodium Agonist / 否
HY-113658 ts-SA / 否
HY-113920 Azumolene sodium Inhibitor / 否
HY-114691 R 59494 Inhibitor / 否
HY-114743 GS 283 Antagonist / 否
HY-114826 Prostaglandin E2-1-glyceryl ester Activator / 否
HY-114990 EMD 57439 Inhibitor / 否
HY-115493 TIQ-15 Antagonist / 否
HY-115767 (±)-1,2-Diolein Activator / 否
HY-115998 Carbonic anhydrase inhibitor 11 Inhibitor / 否
HY-115999 Carbonic anhydrase inhibitor 12 Inhibitor / 否
HY-116153 HUHS2002 / 否
HY-116312 8-pCPT-2′-O-Me-cAMP Activator / 否
HY-116330 Hyperforin / 否
HY-116429A 7(S)-Maresin 1 / 否
HY-116429S Maresin 1-d5 Inhibitor / 否
HY-116500A AH-1058 Antagonist / 否
HY-117099 TMB-8 Antagonist / 否
HY-117578 KB 5666 / 否
HY-118387 AVE-0118 Inhibitor / 否
HY-119919 Clofenamide Inhibitor / 否
HY-120355 AP14145 Inhibitor / 否
HY-120699 RO5488608 Modulator / 否
HY-120764 PF-46396 Inhibitor / 否
HY-120820 LY320954 Antagonist / 否
HY-120985 Araguspongin B Antagonist / 否
HY-121299 m-Chlorophenylbiguanide ≥90.0% 否
HY-121516 CM-TPMF / 否
HY-12153 JNJ-1930942 Modulator / 否
HY-12155 JNJ-26990990 Inhibitor / 否
HY-121690 Semotiadil Antagonist / 否
HY-121966 Riparin 98.00% 否
HY-123434 PD-149164 Agonist / 否
HY-124176 L-6355 / 否
HY-12542S Dantrolene-13C3 Inhibitor 99.0% 否
HY-125641A AL-34662 formate Agonist / 否
HY-12596 JNJ-26489112 / 否
HY-126821 Fluo-3 / 否
HY-126821A Fluo-3 pentaammonium / 否
HY-129088 HUP30 99.68% 否
HY-129547 Fluo-3 pentapotassium / 否
HY-12962A NMDA-IN-1 dihydrochloride Antagonist / 否
HY-130070 QO-40 Activator 98.77% 否
HY-130368 W-7 / 否
HY-131001 DPNB-ABT594 Agonist / 否
HY-131041 Ned-K / 否
HY-131942 sFTX-3.3 Antagonist / 否
HY-132190 Hexanolamino PAF C-16 Antagonist / 否
HY-132239 5-Bromo-6-chloro-3-indolyl β-D-Galactopyranoside contains ca. 10% Ethyl Acetate / 否
HY-133596 12,14-Dichlorodehydroabietic acid / 否
HY-135110 Rp-8-Br-cGMPS sodium / 否
HY-135433 MAPTAM / 否
HY-135478 LY393615 Inhibitor / 否
HY-135601 Cinacalcet metabolite M4 / 否
HY-136189 UK-59811 hydrochloride Inhibitor / 否
HY-136283 DMNPE-4 AM-caged-calcium Ligand / 否
HY-136894 Rhod-5N / 否
HY-13764A dl-Tetrandrine Inhibitor / 否
HY-138951 AY77 Agonist / 否
HY-138990 GK563 Inhibitor / 否
HY-139041 Palmitoylcholine chloride Inhibitor / 否
HY-139145 Etbicyphat Antagonist 98.0% 否
HY-139145S Etbicyphat-13C3 / 否
HY-141712 ZA18 Inhibitor / 否
HY-141713 ZA10 Inhibitor / 否
HY-142050 (R)-IDHP / 否
HY-142087 Beauverolide Ja Inhibitor / 否
HY-142117 Adenophostin A Modulator / 否
HY-143460 CAXII-IN-1 Inhibitor / 否
HY-144222 NSC 828467 Inhibitor / 否
HY-144807 Carbonic anhydrase inhibitor 9 Inhibitor / 否
HY-145196 RTICBM-189 Modulator 99.73% 否
HY-145385 Coelenteramide / 否
HY-145542S Isovalerylcarnitine-d9 chloride / 否
HY-145900 S100A2-p53-IN-1 Inhibitor / 否
HY-146010 Carbonic anhydrase inhibitor 13 Inhibitor / 否
HY-146232 F 13714 Agonist / 否
HY-146252 hCAXII-IN-4 Inhibitor / 否
HY-146259 hCAIX/XII-IN-4 Inhibitor / 否
HY-146461 Anticancer agent 58 / 否
HY-146462 Anticancer agent 59 / 否
HY-14656S1 Diltiazem-(acetoxy-d3) hydrochloride Antagonist / 否
HY-146819 CAIX/CAXII-IN-1 / 否
HY-146982 hCAII-IN-1 Inhibitor / 否
HY-146983 hCAIX-IN-3 Inhibitor / 否
HY-147186 5,5'-Difluoro BAPTA / 否
HY-147377 N-Salicyloyltryptamine 96.37% 否
HY-147383 NS-8 Activator / 否
HY-149011 CA IX-IN-1 Inhibitor / 否
HY-149342 α-Glucosidase-IN-29 Inhibitor / 否
HY-149483 CVN417 Antagonist / 否
HY-150039 CCG-271423 Inhibitor / 否
HY-15016 (E/Z)-OT-R antagonist 1 Antagonist / 否
HY-15018A SSR126768A free base Antagonist / 否
HY-150536 EP39 Inhibitor / 否
HY-150570 Carbonic anhydrase inhibitor 14 Inhibitor / 否
HY-150695 hCAIX/XII-IN-5 / 否
HY-150782 UNC-CA359 Inhibitor / 否
HY-151451 Cav 3.2 inhibitor 2 Inhibitor / 否
HY-151452 Cav 3.2 inhibitor 3 Inhibitor / 否
HY-151472 hCAIX/XII-IN-6 Inhibitor / 否
HY-151493 CAII-IN-1 Inhibitor / 否
HY-151494 CAII-IN-2 Inhibitor / 否
HY-151495 CAII-IN-3 Inhibitor / 否
HY-151547 MRS4719 Antagonist / 否
HY-151547S MRS4719-d3 / 否
HY-151578 DPP IV/hCA II-IN-1 Inhibitor / 否
HY-151633 hCAIX-IN-14 Inhibitor / 否
HY-152140 hCAII-IN-8 Inhibitor 99.41% 否
HY-15293 JTV-519 Inhibitor / 否
HY-155694 hCA/VEGFR-2-IN-1 Inhibitor / 否
HY-156013 CA inhibitor 2 Inhibitor / 否
HY-156082 RyRs activator 3 Inhibitor / 否
HY-156104 CaMKIIα-PHOTAC Degrader / 否
HY-156181 hCAIX/XII-IN-8 Inhibitor / 否
HY-157139 ALP/Carbonic anhydrase-IN-1 Inhibitor 99.90% 否
HY-158328A CA IX/VEGFR-2-IN-2 / 否
HY-159122 CA IX-IN-2 / 否
HY-159861 Ionizable Lipid 4 / 否
HY-160508 NCX1-IN-1 Inhibitor / 否
HY-160962 SM1044 / 否
HY-160998 YM-344031 Antagonist / 否
HY-161143 Carbonic anhydrase/AChE-IN-2 Inhibitor / 否
HY-161388 NSCLC-IN-1 Inducer / 否
HY-162000 hCAIX/XII-IN-13 Inducer / 否
HY-162005 AChE-IN-48 Inhibitor / 否
HY-162063 hCAIX/XII-IN-9 Inhibitor / 否
HY-162280 PROTAC BTK Degrader-9 / 否
HY-162331 STING Degrader-1 Degrader / 否
HY-162344 Ir-CA Inducer / 否
HY-162374 ANO61 Inhibitor / 否
HY-162375 AF299 / 否
HY-162521 Antibacterial agent 215 Inhibitor / 否
HY-162526 HIV capsid modulator 2 Modulator / 否
HY-163116 Anti-inflammatory agent 67 Inhibitor / 否
HY-163117 Anti-inflammatory agent 68 Inhibitor / 否
HY-163380 CA/MAO-B-IN-1 Inhibitor 98.34% 否
HY-163795 GPR183-IN-1 Inhibitor / 否
HY-164682 AMD 3329 octahydrobromide Inhibitor / 否
HY-164684 Dichlorobenzamil Inhibitor / 否
HY-167091 (Rac)-Beraprost / 否
HY-168320 N-Stearoyltyrosine Inhibitor / 否
HY-168603 AChE/CA I-IN-1 Inhibitor / 否
HY-168604 CA Ⅱ-IN-1 Inhibitor / 否
HY-169115A (Rac)-PD0299685 Ligand / 否
HY-169162 hBChE-IN-3 / 否
HY-169209 CA-M11 Inhibitor / 否
HY-169845 Calcium Channel antagonist 6 Antagonist / 否
HY-170424 D-myo-Inositol-1,3,4,5-tetrakisphosphate potassium / 否
HY-170541 FUT8-IN-1 Inhibitor / 否
HY-170551 CA IX/VEGFR-2-IN-3 Inhibitor / 否
HY-170558 FW-1 / 否
HY-170560 AChE/hCA I-IN-1 Inhibitor / 否
HY-170893 CAIX/CAXII-IN-4 Inhibitor / 否
HY-172772 Anti-PEDV agent 1 Inhibitor / 否
HY-172899 Carbonic anhydrase inhibitor 33 / 否
HY-172950 CAXII-IN-2 Inhibitor / 否
HY-172964 KIM-161 / 否
HY-173194 Carbonic anhydrase inhibitor 29 Inhibitor / 否
HY-173321 PAD4-IN-5 Inhibitor / 否
HY-173537 D-myo-Inositol-1,2,4,5-tetraphosphate tetrasodium salt / 否
HY-173618 LQFM020 / 否
HY-17404S Cilnidipine-d7 Inhibitor / 否
HY-174140 VU0514009 Antagonist / 否
HY-174232 EGFR/CA-IX-IN-1 / 否
HY-174269 HIV Capsid-IN-2 Inhibitor / 否
HY-174835 hCA-I/hCA-II-IN-1 Inhibitor / 否
HY-175021 HDAC-IN-91 / 否
HY-175219 CA-II/Dkk1-IN-1 Inhibitor / 否
HY-175441 Carbonic anhydrase activator 1 Activator / 否
HY-175593 M6766 / 否
HY-175638 Carbonic anhydrase-IN-35 / 否
HY-175675 P2Y1 antagonist 4 / 否
HY-176021 U-44069 serinol amide / 否
HY-176041 Troponin modulator 1 / 否
HY-176147 Apoptosis inducer 38 Inducer / 否
HY-176745 SW016789 Inducer 99.85% 否
HY-177091 AS2795440 Inhibitor / 否
HY-177296 GPR40 agonist 8 Agonist / 否
HY-178030 CAXII-IN-3 / 否
HY-178144 FPR2 agonist 5 / 否
HY-19025 CV-159 Antagonist / 否
HY-19044 SKF 95601 / 否
HY-19409 AJG049 Antagonist / 否
HY-19857 Sulcardine sulfate / 否
HY-34740S1 Ethylmalonic acid-d5 Inhibitor 98.09% 否
HY-70037S Cinacalcet-D3 Agonist / 否
HY-A0057AS2 Gabapentin-d4 hydrochloride Inhibitor / 否
HY-B0006CS (R)-Carvedilol-d4 Inhibitor / 否
HY-B0109AS1 Dorzolamide-d5(hydrochloride) Inhibitor / 否
HY-B0246S4 Carbamazepine-d4 / 否
HY-B0358AS Flunarizine-d8 dihydrochloride / 否
HY-B0380S1 Trimebutine-d5 fumarate / 否
HY-B0380S2 Trimebutine-d3 hydrochloride / 否
HY-B0588AS Brinzolamide-d5 hydrochloride / 否
HY-B0596S Taltirelin-13C,d3 / 否
HY-B0684S1 Iopamidol-d3 / 否
HY-B1221S Flufenamic acid-d4 / 否
HY-B1726 Phenacaine Inhibitor / 否
HY-B1837A β-Cyfluthrin Inhibitor 99.94% 否
HY-B1837AR β-Cyfluthrin (Standard) Inhibitor / 否
HY-CE01249 CA-CoA / 否
HY-D0121 INDO 1 / 否
HY-D0121B INDO 1 pentasodium / 否
HY-D0157 ZnAF-2 / 否
HY-D0861A EGTA tetrasodium / 否
HY-D1424 Coelenterazine hcp / 否
HY-D1501 Fura PE-3 potassium / 否
HY-D1608 BODIPY FL Thapsigargin Inhibitor / 否
HY-D1616 5-Bromo-5'-methyl BAPTA tetramethyl ester / 否
HY-D1631A Calcium green-5N hexapotassium / 否
HY-D1636 5-Nitro BAPTA / 否
HY-D1640 5',5-Difluoro BAPTA tetrapotassium / 否
HY-D1643 5,5'-Dinitro BAPTA AM / 否
HY-D1700 Mag-indo-1/AM / 否
HY-D1702 Mag-Fura-2 tetrapotassium / 否
HY-D1755 Fluo-3FF AM / 否
HY-E70197 Calpain-1 (pig) / 否
HY-E70234A Sortase A, S. aureus (non-Ca²⁺-dependent) / 否
HY-E70813 CAMKK2 Recombinant Human Active Protein Kinase / 否
HY-I0096S Indole-2-carboxylic acid-13C Inhibitor / 否
HY-N0043R Ginsenoside Rd (Standard) Inhibitor / 否
HY-N0081A (-)-Praeruptorin A Inhibitor / 否
HY-N0215S13 L-Phenylalanine-d1 Antagonist 99.5% 否
HY-N0215S6 DL-Phenylalanine-d5 hydrochloride Antagonist / 否
HY-N0215S9 L-Phenylalanine-13C9,15N,d8 Antagonist / 否
HY-N0219R Bicuculline (Standard) Antagonist / 否
HY-N0252B Catharanthine Sulfate Inhibitor / 否
HY-N10512 Gangliotetraose / 否
HY-N10754 Aschantin Inhibitor / 否
HY-N11887 Linocinnamarin Inhibitor / 否
HY-N1228 Soyacerebroside I / 否
HY-N12455 Comosone II / 否
HY-N12726 Halociline Inhibitor / 否
HY-N15735 Cimicifugic acid D Inhibitor / 否
HY-N15737 Fukinolic acid Inhibitor / 否
HY-N16129 Diplacone / 否
HY-N3729 (-)-Denudatin B Inhibitor ≥97.0% 否
HY-N4237 Saikogenin D 99.99% 否
HY-N5123 α-L-Rhamnose / 否
HY-N7063R Nerol (Standard) / 否
HY-N7594 Senecionine acetate / 否
HY-N7875 Celangulin / 否
HY-NP164A Concanavalin A-Cy5.5 / 否
HY-NP164C Concanavalin A-AF350 / 否
HY-NP164E Concanavalin A-AF430 / 否
HY-NP164I Concanavalin A-AF546 / 否
HY-NP164J Concanavalin A-AF555 / 否
HY-NP164L Concanavalin A-AF647 / 否
HY-NP164N Concanavalin A-Cy3 / 否
HY-NP164O Concanavalin A-Cy5 / 否
HY-P0033A Argireline acetate Inhibitor / 否
HY-P0188 ω-Conotoxin MVIIC Inhibitor / 否
HY-P0189 ω-Conotoxin GVIA Inhibitor / 否
HY-P10316 CaMKI(299-320) Modulator / 否
HY-P10328 Vasoactive intestinal contractor Inhibitor / 否
HY-P10371 PKHB1 Activator / 否
HY-P1075A CALP3 TFA Inhibitor / 否
HY-P1076 CALP2 Antagonist / 否
HY-P10773 CTP-amiodarone Inhibitor / 否
HY-P1080 ω-Agatoxin IVA Inhibitor / 否
HY-P10805 Capsid assembly inhibitor Inhibitor / 否
HY-P10811 Na2+ - Ca2+ Exchanger inhibitory peptide Inhibitor / 否
HY-P10972 GIP (22-51) human / 否
HY-P11019 IS4 Antagonist / 否
HY-P11082 APGW-amide / 否
HY-P11205 Cys-PKHB1 Activator / 否
HY-P11292 Caloxin 1b3 Inhibitor / 否
HY-P1247A Calcineurin autoinhibitory peptide TFA Inhibitor / 否
HY-P1250A RFRP-3(human) TFA Agonist / 否
HY-P1345 TLQP-21 Agonist / 否
HY-P1366A des-​Gln14-​Ghrelin TFA / 否
HY-P1437A Neuropeptide S(Mouse) TFA Agonist / 否
HY-P2424 Cholecystokinin-J / 否
HY-P2722 Bovine brain Calcineurin / 否
HY-P3089 Dendrotoxin K Inhibitor / 否
HY-P3168 Martentoxin Inhibitor / 否
HY-P3187A exo-β-1,4-xylosidase, Clostridium stercorarium / 否
HY-P3187B exo-β-1,4-xylosidase, Bacteroides ovatus / 否
HY-P3316 OSK-1 Inhibitor / 否
HY-P3679 Neuropeptide Y (1-24) (human) Activator / 否
HY-P3811 Autocamtide-3 / 否
HY-P3943 Calmodulin Dependent Protein Kinase Substrate Analog / 否
HY-P3944 Calmodulin Dependent Protein Kinase Substrate / 否
HY-P4368 Z-APF-CMK Inhibitor / 否
HY-P4397 (d(CH2)51,Tyr(Me)2,Thr4,Orn8,des-Gly-NH29)-Vasotocin / 否
HY-P5154 Tamapin Antagonist / 否
HY-P5319 MCaE12A / 否
HY-P5422 Caloxin 3A1 Inhibitor / 否
HY-P5796 FS-2 Inhibitor / 否
HY-P5799 ω-Conotoxin MVIID Inhibitor / 否
HY-P5802 ω-Conotoxin FVIA Inhibitor / 否
HY-P5805 ω-Conotoxin CVIE Inhibitor / 否
HY-P5813 Cd1a Inhibitor / 否
HY-P5869 Kurtoxin / 否
HY-P5870 KTX-Sp2 Inhibitor / 否
HY-P6008 Myoregulin / 否
HY-P6008A Myoregulin TFA / 否
HY-P6013 wt hMLN Inhibitor / 否
HY-P6292 KS-133 Antagonist / 否
HY-RS01762 CA1 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS01763 CA10 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS01764 CA11 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS01765 CA12 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS01766 CA13 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS01767 CA14 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS01768 CA2 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS01769 CA3 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS01770 CA4 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS01771 CA5A Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS01772 CA5B Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS01773 CA6 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS01774 CA7 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS01775 CA8 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS01850 CALY Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS10524 Pik3ca Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS10525 Pik3ca Rat Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS10973 PPP1CA Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS11023 PPP3CA Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-U00026 Semotiadil recemate fumarate / 否
HY-W040028 Cartap hydrochloride Inducer / 否
HY-W170020 PTCA Ligand 99.72% 否
HY-W339833 1-Myristoyl-2-hydroxy-sn-glycero-3-phosphate sodium / 否
HY-W403046A D-myo-Inositol-4-phosphate monoammonium Activator / 否
HY-W414824 3β,7β-Dihydroxy-5-cholestenoic acid / 否
HY-W424792A O-Desmethyl Brinzolamide hydrochloride Inhibitor / 否
HY-W641445 ELP-004 Inhibitor / 否
HY-W707161 4-Methyl-2-(1-piperidinyl)-quinoline-d10 / 否
HY-W710915 Aprindine hydrochloride-d10 Inhibitor / 否
HY-W711474 (-)-Menthol-d4 / 否
HY-W721517 Gabapentin-d10 / 否
HY-W748509 Pipernonaline / 否
HY-W783254 C18 LPA / 否
HY-Z8176 (Z)-Flunarizine Inhibitor / 否
HY-101616 ABT-639 hydrochloride Inhibitor / 否
HY-101669 TDN345 Antagonist / 否
HY-101685 Iganidipine Antagonist / 否
HY-101727 Nexopamil racemate / 否
HY-10341D Fasudil mesylate / 否
HY-108163 SB-237376 free base Antagonist / 否
HY-108984 BBMP / 否
HY-110091 TRPV1 antagonist 9 Antagonist / 否
HY-113037AS Farnesyl pyrophosphate-d6 Agonist / 否
HY-113308AS1 Taurolithocholic Acid-d5 sodium salt Agonist / 否
HY-113723 MRS2298 Antagonist / 否
HY-115231 ci-IP3/PM / 否
HY-115767S (±)-1,2-Diolein-13C3 Activator / 否
HY-116072 Antiarrhythmic agent-2 Inhibitor / 否
HY-116143 MAGL-IN-12 Inhibitor / 否
HY-116191 WJD008 Inhibitor / 否
HY-116723 CFMMC Antagonist / 否
HY-117055 Ro 18-3981 Inhibitor / 否
HY-117982 SKI2496 / 否
HY-121366 Kadethrin Inhibitor / 否
HY-121720 L 657925 Antagonist / 否
HY-121914 (2-Chlorophenyl)diphenylmethanol Inhibitor 99.56% 否
HY-129334 Macrocalin B Inhibitor / 否
HY-130358 PDDHV Activator / 否
HY-131764 2'-O-MB-cGMP sodium Inhibitor / 否
HY-133614 Dihydroisopimaric acid Activator / 否
HY-134368 Ap3A Inhibitor / 否
HY-135110A Rp-8-Br-cGMPS / 否
HY-135317C Emavusertib tosylate / 否
HY-135317D Emavusertib mesylate / 否
HY-135317E Emavusertib maleate / 否
HY-135317F Emavusertib phosphate / 否
HY-135478A LY393615 free base Inhibitor / 否
HY-136784A Rhod-2 sodium / 否
HY-137172 ETH 157 / 否
HY-141613A Dioleyl phosphatidylserine Activator / 否
HY-14477 UPF-1035 Inhibitor / 否
HY-14656S2 Diltiazem-d6 hydrochloride Antagonist / 否
HY-147301B Resomelagon methanesulfonate Agonist / 否
HY-149779 RyR2 stabilizer-1 Modulator / 否
HY-152051S Mabuterol-d9 hydrochloride Agonist / 否
HY-154924 Thio-NADP / 否
HY-157321 hCAI/II-IN-7 Inhibitor / 否
HY-159870 E12CA1A3 / 否
HY-161848 TCP-MP-CA Inhibitor / 否
HY-163660 Carbonic anhydrase inhibitor 23 Inhibitor / 否
HY-166363S Beraprost-d3 / 否
HY-167203 AJG049 free base Antagonist / 否
HY-168377 Fluo-4 potassium / 否
HY-168382 5R(6S)-EET Agonist / 否
HY-168382A 5S(6R)-EET Agonist / 否
HY-168767 CA IX-IN-3 Inhibitor / 否
HY-169206 PF-3166 Inhibitor / 否
HY-16935S Mavatrep-d6 Antagonist / 否
HY-169780 (S)-AMG-628 Antagonist / 否
HY-171187 Chlorzolamide Inhibitor / 否
HY-171469 SKP-451 Agonist / 否
HY-172321 Etheno-NAADP sodium / 否
HY-17404S1 Cilnidipine-d4 Inhibitor / 否
HY-174685 Human FLI1 mRNA / 否
HY-174829 7,4'-Dimethoxy-3-hydroxyflavone / 否
HY-19062 SM-6586 / 否
HY-A0082S Diphenidol-d10 hydrochloride Antagonist / 否
HY-B0021S1 Doxifluridine-d3 Inhibitor / 否
HY-B0109AS Dorzolamide-d3 hydrochloride Inhibitor / 否
HY-B0109S Dorzolamide-d5 Inhibitor / 否
HY-B0493S Niflumic Acid-d5 Inhibitor / 否
HY-B0632B (2R,3R)-Diltiazem hydrochloride Inhibitor / 否
HY-B0632S2 Diltiazem-d4 Inhibitor / 否
HY-B0684S Iopamidol-d8 / 否
HY-B1193S Terfenadine-d3 / 否
HY-D0110B Fura-2 pentasodium / 否
HY-N12164 Linearmycin B Inhibitor / 否
HY-N1369S1 Menthol-d2 Modulator / 否
HY-N13916 Alternaric acid / 否
HY-N14440 Furaquinocin C / 否
HY-N7063S Nerol-d2 / 否
HY-N7063S1 Nerol-d6 / 否
HY-N8112 Polygalasaponin LII / 否
HY-N9484S Menthofuran-13C2 / 否
HY-N9485 25(R)-Hydroxyprotopanaxadiol / 否
HY-RS19521 Ppp3ca Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS20700 Caly Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS26016 Ppp3ca Rat Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS27211 Caly Rat Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS27691 Ppp2ca Rat Pre-designed siRNA Set A Pre-designed Set / 否
HY-W150752 Triphenylethylene 99.86% 否
HY-W288025 ALXR-agonist-6 Agonist / 否
HY-W587689 Juvenile hormone B 3 (mixture of diastereomers) / 否
HY-W653978 Cinacalcet-d4 hydrochloride Agonist / 否
HY-W654243 Isovalerylcarnitine-d9-1 chloride Activator / 否
HY-W755295 Mabuterol hydrochloride Agonist / 否
HY-W931056 AMG-628 Inhibitor / 否
HY-132191 Pradimicin A Inhibitor / 否
HY-P1479 Calmodulin-Dependent Protein Kinase II (290-309) / 否
HY-U00354 CP-060 Antagonist / 否
抗体抑制剂 (3)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-P990830 Anti-MUC16 Antibody (VK8) Inhibitor / 否
HY-P991646 ING-1 / 否
HY-P991649 Anti-CA6 Antibody (huDS6) / 否

直系同源

种属 基因名 来源 基因 ID
Bos taurus CALY VGNC VGNC:26718
Macaca mulatta CALY VGNC VGNC:70575
Rattus norvegicus CALY RGD RGD:621719
Canis familiaris CALY VGNC VGNC:38676
Mus musculus CALY MGD MGI:1915816
Others CALY NCBI
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z